Revenue during the quarter grew 3.41 percent to $726.80 million from $702.80 million in the previous year period. Gross margin for the quarter expanded 189 basis points over the previous year period to 55.88 percent. Total expenses were 79.76 percent of quarterly revenues, down from 82.11 percent for the same period last year. This has led to an improvement of 235 basis points in operating margin to 20.24 percent.

Operating income for the quarter was $147.10 million, compared with $125.70 million in the previous year period.

However, the adjusted operating income for the quarter stood at $242.20 million compared to $235.40 million in the prior year period. At the same time, adjusted operating margin contracted 17 basis points in the quarter to 33.32 percent from 33.49 percent in the last year period.

"We closed out a very successful fiscal year with another strong performance in the fourth quarter," said Steve MacMillan, Hologic's chairman, president and chief executive officer. "Our results demonstrate that we are making good progress in building a sustainable growth company, and we look forward to more successes in 2017 based on the strength of our product franchises and the dedication of our people."

For financial year 2017, Hologic, Inc. projects revenue to be in the range of $2,940 million to $2,980 million. It projects adjusted revenue to be in the range of $2,940 million to $2,980 million. It forecasts diluted earnings per share to be in the range of $1.23 to $1.27. It forecasts diluted earnings per share to be in the range of $2.12 to $2.16 on adjusted basis for the same period. 

For the first-quarter, Hologic, Inc. projects revenue to be in the range of $720 million to $730 million. It projects adjusted revenue to be in the range of $720 million to $730 million. It forecasts diluted earnings per share to be in the range of $0.26 to $0.27. It forecasts diluted earnings per share to be in the range of $0.50 to $0.51 on an adjusted basis for the same period.

The company has spent $68.40 million cash to meet investing activities during the year as against cash outgo of $86.10 million in the last year.

The company has spent $659.70 million cash to carry out financing activities during the year as against cash outgo of $936.70 million in the last year period.

Working capital increases sharply
Hologic, Inc. has recorded an increase in the working capital over the last year. It stood at $424.70 million as at Sep. 24, 2016, up 31.73 percent or $102.30 million from $322.40 million on Sep. 26, 2015. Current ratio was at 1.47 as on Sep. 24, 2016, up from 1.34 on Sep. 26, 2015.

Debt comes down
Hologic, Inc. has recorded a decline in total debt over the last one year. It stood at $3,345.40 million as on Sep. 24, 2016, down 7.39 percent or $266.80 million from $3,612.20 million on Sep. 26, 2015. Total debt was 45.72 percent of total assets as on Sep. 24, 2016, compared with 47.09 percent on Sep. 26, 2015. Debt to equity ratio was at 1.56 as on Sep. 24, 2016, down from 1.74 as on Sep. 26, 2015. Interest coverage ratio improved to 3.88 for the quarter from 2.46 for the same period last year.